Cost‐effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals
Open Access
Abstract
BACKGROUND: Colorectal cancer (CRC) screening is underused by minority populations, and patient navigation increases adherence with screening colonoscopy. In this study, the authors estimated the cost‐effectiveness of navigation for screening colonoscopy from the perspective of a payer seeking to improve population health.METHODS: A validated model of CRC screening was informed with inputs from navigation studies in New York City (population: 43% African American, 49% Hispanic, 4% white, 4% other; base‐case screening: 40% without navigation, 65% with navigation; navigation costs: $29 per colonoscopy completer, $21 per noncompleter, $3 per non‐navigated individual). Two analyses compared: 1) navigation versus no navigation for 1‐time screening colonoscopy in unscreened individuals aged ≥50 years; and 2) programs of colonoscopy with versus without navigation versus fecal occult blood testing (FOBT) or fecal immunochemical testing (FIT) for individuals ages 50 to 80 years.RESULTS: In the base case: 1) 1‐time navigation gained quality‐adjusted life‐years (QALYs) and decreased costs; 2) longitudinal navigation cost $9800 per QALY gained versus no navigation, and, assuming comparable uptake rates, it cost $118,700 per QALY gained versus FOBT but was less effective and more costly than FIT. The results were most dependent on screening participation rates and navigation costs: 1) assuming a 5% increase in screening uptake with navigation, and a navigation cost of $150 per completer, 1‐time navigation cost $26,400 per QALY gained; and 2) longitudinal navigation with 75% colonoscopy uptake cost <$25,000 per QALY gained versus FIT when FIT uptake was Cancer 2015;121:1088–1097.©2014 American Cancer Society.Keywords
Funding Information
- National Cancer Institute (CA120658)
This publication has 43 references indexed in Scilit:
- Comparative Effectiveness and Cost-Effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative StrategiesAmerican Journal of Gastroenterology, 2013
- Colorectal-Cancer Incidence and Mortality with Screening Flexible SigmoidoscopyNew England Journal of Medicine, 2012
- Risk of colorectal adenomas and advanced neoplasia in Hispanic, black and white patients undergoing screening colonoscopyAlimentary Pharmacology & Therapeutics, 2012
- Adherence to Colorectal Cancer ScreeningArchives of internal medicine (1960), 2012
- Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer DeathsNew England Journal of Medicine, 2012
- Cost-effectiveness of Colorectal Cancer ScreeningEpidemiologic Reviews, 2011
- Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trialThe Lancet, 2010
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyGastroenterology, 2008
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996